Granahan Investment Management - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,285,884
+10.9%
939,209
+15.9%
0.58%
+28.3%
Q2 2023$14,683,669
+6.4%
810,357
+56.1%
0.45%
+7.6%
Q1 2023$13,804,469
+41.4%
518,965
+2.7%
0.42%
+40.5%
Q4 2022$9,765,207
+22.7%
505,184
+32.6%
0.30%
+15.0%
Q3 2022$7,961,000
+87.6%
381,093
-28.1%
0.26%
+79.3%
Q2 2022$4,244,000
+23.7%
529,811
+8.3%
0.14%
+70.6%
Q1 2022$3,430,000
-7.0%
489,334
+79.1%
0.08%
+11.8%
Q4 2021$3,688,000273,1850.08%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 339,160$5,881,034100.00%
CHI Advisors LLC 3,014,199$52,266,21120.72%
TRV GP IV, LLC 2,132,867$36,983,91413.93%
GREAT POINT PARTNERS LLC 1,755,184$30,434,8915.54%
First Light Asset Management, LLC 2,933,260$50,862,7284.83%
Deep Track Capital, LP 5,500,000$95,370,0003.68%
Casdin Capital, LLC 1,577,108$27,347,0533.03%
Fernwood Investment Management, LLC 379,702$6,584,0332.37%
Redmile Group, LLC 2,678,099$46,438,2372.21%
SILVERARC CAPITAL MANAGEMENT, LLC 250,409$4,342,0921.32%
View complete list of PLIANT THERAPEUTICS INC shareholders